Literature DB >> 2749101

New spectrum of fungal infections in patients with cancer.

E Anaissie1, G P Bodey, H Kantarjian, J Ro, S E Vartivarian, R Hopfer, J Hoy, K Rolston.   

Abstract

We report on 44 cancer patients who had serious infections with unusual fungal pathogens and who were cared for at our cancer center between 1974 and 1986. Twelve different fungal species accounted for these infections, including Trichosporon beigelii, Fusarium species, Geotrichum candidum, Curvularia species, Drechslera species, Penicillium species (but not Penicillium marneffei), Rhodotorula rubra, Pseudallescheria boydii, Pichia farinosa, Torulopsis pintolopesii, Saccharomyces cerevisiae, and Cunninghamella bertholletiae. Skin lesions were noted in seven patients, and sinusitis occurred in four. Twenty-four patients had disseminated infection, 12 had involvement of a single organ, and eight had fungemia alone. Features that correlated with a poor prognosis were persistent neutropenia and disseminated visceral infection but not fungemia alone. We suggest that unusual fungi have now emerged as significant pathogens in this patient population. Fungal sinusitis, previously caused by Aspergillus species and the phycomycetes, also occurs as a result of some of these newly recognized fungi. A high level of suspicion should be maintained when any of these unusual fungi are cultured from clinical specimens from immunocompromised patients.

Entities:  

Mesh:

Year:  1989        PMID: 2749101     DOI: 10.1093/clinids/11.3.369

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  46 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Contributions to a revision of the genus Trichosporon.

Authors:  E Guého; M T Smith; G S de Hoog; G Billon-Grand; R Christen; W H Batenburg-van der Vegte
Journal:  Antonie Van Leeuwenhoek       Date:  1992-05       Impact factor: 2.271

3.  Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.

Authors:  Carolina Serena; Félix Gilgado; Marçal Mariné; F Javier Pastor; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Pichia farinosa bloodstream infection in a lymphoma patient.

Authors:  A Adler; C Hidalgo-Grass; T Boekhout; B Theelen; E Sionov; I Polacheck
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

5.  Three cases of infection with Fusarium species in neutropenic patients.

Authors:  M Nucci; N Spector; S Lucena; P C Bacha; W Pulcheri; A Lamosa; A Derossi; M J Caiuby; J Macieira; H P Oliveira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

6.  Eukaryotic diversity in an anaerobic aquifer polluted with landfill leachate.

Authors:  Traian Brad; Martin Braster; Boris M van Breukelen; Nico M van Straalen; Wilfred F M Röling
Journal:  Appl Environ Microbiol       Date:  2008-05-09       Impact factor: 4.792

7.  Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.

Authors:  E J Anaissie; R Hachem; N C Karyotakis; A Gokaslan; M C Dignani; L C Stephens; C K Tin-U
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

8.  Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.

Authors:  A Gehrt; J Peter; P A Pizzo; T J Walsh
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia.

Authors:  B H Segal; T J Walsh; J M Liu; J D Wilson; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Successful treatment of a brain abscess due to Trichoderma longibrachiatum after surgical resection.

Authors:  P Seguin; B Degeilh; I Grulois; A Gacouin; S Maugendre; T Dufour; B Dupont; C Camus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.